无症状菌尿是门诊肝硬化患者尿路感染的独立预测因素:一项前瞻性评估。
Asymptomatic bacteriuria is an independent predictor of urinary tract infections in an ambulatory cirrhotic population: a prospective evaluation.
作者信息
Ye Carrie, Kumar Deepali, Carbonneau Michelle, Keough Adam, Ma Mang, Tandon Puneeta
机构信息
Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
出版信息
Liver Int. 2014 Jul;34(6):e39-44. doi: 10.1111/liv.12435. Epub 2014 Jan 7.
BACKGROUND & AIMS: Asymptomatic bacteriuria (ASB) is a risk factor for urinary tract infections (UTIs) in many patients without liver disease. It remains unclear whether a diagnosis of ASB in an outpatient with cirrhosis could be utilized to predict the subsequent development of a UTI. We undertook this study to determine the prevalence and incidence of ASB in an outpatient population and its association with UTI.
METHODS
We prospectively evaluated 108 adult outpatients with cirrhosis over a 6-month period. Monthly midstream urines (MSU) were performed to detect the occurrence of UTI and ASB (culture of ≥10(8) CFU/L of a urinary pathogen in the absence of UTI symptoms).
RESULTS
Of 108 patients enrolled, 99 completed at least one MSU, for a total of 489 MSUs. Total follow-up was 44 person-years. The incidences of ASB and UTI were 181 and 250 per 1000 person-years, respectively. The prevalences of ASB and UTI on the first MSU were 5 and 1%, respectively. In total, 8% of patients developed an episode of ASB and 11% developed a UTI during the study period. Univariate predictors of UTI were female gender, primary biliary cirrhosis, number of previous UTIs and preceding ASB. Preceding ASB was the only independent predictor of UTI on multivariate analysis, with an odds ratio of 6.2 (1.1-34.3), P = 0.04.
CONCLUSIONS
Cirrhotic patients have higher rates of ASB and UTI than reported in the general population. ASB is an independent predictor of UTI. Further studies are necessary to determine whether routine screening and antimicrobial treatment of ASB is warranted.
背景与目的
无症状菌尿(ASB)是许多无肝脏疾病患者发生尿路感染(UTI)的危险因素。肝硬化门诊患者的ASB诊断能否用于预测随后UTI的发生尚不清楚。我们开展本研究以确定门诊患者中ASB的患病率和发病率及其与UTI的关联。
方法
我们对108例成年肝硬化门诊患者进行了为期6个月的前瞻性评估。每月进行一次中段尿(MSU)检查以检测UTI和ASB的发生情况(在无UTI症状的情况下,尿病原体培养≥10⁸CFU/L)。
结果
108例入组患者中,99例完成了至少一次MSU检查,共进行了489次MSU检查。总随访时间为44人年。ASB和UTI的发病率分别为每1000人年181例和250例。首次MSU检查时ASB和UTI的患病率分别为5%和1%。在研究期间,总共8%的患者发生了ASB发作,11%的患者发生了UTI。UTI的单因素预测因素为女性、原发性胆汁性肝硬化、既往UTI次数和先前的ASB。在多因素分析中,先前的ASB是UTI的唯一独立预测因素,比值比为6.2(1.1 - 34.3),P = 0.04。
结论
肝硬化患者的ASB和UTI发生率高于普通人群报道的水平。ASB是UTI的独立预测因素。有必要进一步研究以确定是否有必要对ASB进行常规筛查和抗菌治疗。